Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
VP7-2021: KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab + chemotherapy vs. placebo + chemotherapy, followed by adjuvant pembrolizumab vs. placebo for early-stage TNBC
Peter Schmid, Javier Cortés, Rebecca Alexandra Dent, Lajos Pusztai, HL McArthur, Sherko Kümmel and 14 more
- Rank
- 49 of 3,031
- Percentile
- top 1.7%
- Where
- Annals of Oncology, 2021
- Citations
- 135
From the 2021 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.